Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
05/2004
05/27/2004WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
05/27/2004US20040102635 Herbicides for combating weeds, preparation by mixing with extenders, surfactants; a tetrazolinone benzoyl with cyclohexyl-, isoxazole-, pyrazole-, or oxomethylene-derivatives
05/27/2004US20040102634 For therapy and prophylaxis of hyperglycemia, hyperlipemia and inflammatory disease
05/27/2004US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections
05/27/2004US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/27/2004US20040102510 Cancer; the compounds interact with the amino acids in the catalytic region of PKs and bind in the general space normally occupied by the adenine ring of ATP
05/27/2004US20040102508 Naphathalene derivatives which bind to the ep4 receptor
05/27/2004US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
05/27/2004US20040102500 Peroxisome proliferator activated receptor alpha agonists
05/27/2004US20040102498 Estrogen receptor modulators
05/27/2004US20040102497 Novel inhibitors of IMPDH enzyme
05/27/2004US20040102496 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
05/27/2004US20040102495 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
05/27/2004US20040102494 Novel heterocyclic compounds having antibacterial activity: process for their preparation and pharmaceutical compositions containing them
05/27/2004US20040102489 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
05/27/2004US20040102483 Chemical compounds
05/27/2004US20040102479 Novel benzopyran or thiobenzopyran derivatives
05/27/2004US20040102450 Substituted oxoazaheterocyclyl compounds
05/27/2004US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
05/27/2004US20040102435 Alzheimer's disease; psychological disorders; anxiolytic agents; antidepressants; hormone replacement therapy
05/27/2004US20040102432 Asthma, rhinitis therapy
05/27/2004US20040102428 Chemokine receptor binding heterocyclic compounds
05/27/2004US20040102423 Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failure
05/27/2004US20040102418 Compounds for the treatment of inflammatory disorders
05/27/2004CA2765093A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004CA2504766A1 2-pyridone derivatives as inhibitors of neutrophile elastase
05/27/2004CA2504737A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/27/2004CA2501932A1 Use of benzimidazole quinolinones for treating cancer
05/26/2004EP1422553A1 Improved base precursors for use in a photothermographic element
05/26/2004EP1422218A1 Antiviral agent
05/26/2004EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
05/26/2004EP1421081A1 Method of mycophenolate mofetil preparation
05/26/2004EP1421079A1 Novel compounds
05/26/2004EP1421078A1 Beta-3 adrenergic agonists
05/26/2004EP1421074A1 Novel compounds
05/26/2004EP1421071A2 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
05/26/2004EP1421070A1 New piperidinyl derivates as modulators of chemokine receptor activity
05/26/2004EP1420784A1 Compounds effecting glucokinase
05/26/2004EP1117661B1 Propanolamine derivatives substituted with heterocyclic compounds, methods for their production, pharmaceutical compositions containing said compounds and the use thereof
05/26/2004EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use
05/26/2004EP1027332B1 Novel lactam metalloprotease inhibitors
05/26/2004EP1022272B1 Substituted fused heterocyclic compounds
05/26/2004EP1005445B1 N-alkanoylphenylalanine derivatives
05/26/2004EP0968194B1 Atropisomers of 3-aryl-4(3h)-quinazolinones and their use as ampa-receptor antagonists
05/26/2004CN1500082A Cyano-5ubstituted dihydropyrimidine compounds and their use to treat diseases
05/26/2004CN1500081A Thiohydantonins and use thereof for treating diabetes
05/26/2004CN1500080A 稠合杂环化合物 Fused heterocyclic compounds
05/26/2004CN1499970A Use of GAL3 receptor antagonists for treatment of. depression and/or anxiety and compounds useful in such methods
05/26/2004CN1151150C Non-peptide angiotonin II receptor antagon Jw sartan compounds and its synthesizing process and application
05/26/2004CN1151147C Indole derivatives as 5-HT receptor antagonist
05/26/2004CN1151133C Anthranilic acid amides and use thereof as medicaments
05/26/2004CN1151131C Piperidine derivatives useful as CCR5 antagonists
05/25/2004US6740760 Such as 1-((s)-3-mercapto-2-methyl-propionyl)-(r)-pyrrol-idine-2-carboxylic acid for treating diseases associated with amyloidosis (alzheimer's disease, diabetes, and familial amyloid polyneuropathy)
05/25/2004US6740754 Process to produce oxazolidinones
05/25/2004US6740682 Treatment of thrombotic diseases, asthma, emphysema, cirrhosis, arthritis, carcinoma, melanoma, restenois, atheroma, trauma, shock and reperfusion injury.
05/25/2004US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
05/25/2004US6740652 Topical administration of an ophthalmologically effective amount of an oxazolidinone derivative
05/25/2004US6740651 Aminoquinazolines which inhibit signal transduction mediated by tyrosine kinases
05/25/2004US6740649 Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- α converting enzyme (TACE)
05/21/2004WO2004041814A1 Heteroaryl-pyramidine derivatives as jak inhibitors
05/21/2004WO2004041792A1 Substituted benzoxazinones and uses thereof
05/21/2004WO2004041788A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
05/21/2004WO2004041782A1 Indoles useful in the treatment of androgen-receptor related diseases
05/21/2004WO2004041781A1 Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones
05/21/2004WO2004041279A1 Gamma-aminoamide modulators of chemokine receptor activity
05/21/2004WO2004041275A1 Substituted 4-alkoxyoxazol derivatives as ppar agonists
05/21/2004WO2004041273A1 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-α]IMIDAZOLE-3-SULFONYL]-PYRROLIDINE-2-CARBOXYLIC ACID AMIDE AS ANTI-INFLAMMATORY AGENTS
05/21/2004WO2004041210A2 Antibacterial agents
05/21/2004WO2004041209A2 Transcription factor modulating compounds and methods of use thereof
05/21/2004WO2004041201A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
05/21/2004WO2004041163A2 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
05/21/2004WO2004014860A3 Fused heterocyclic compounds as peptidase inhibitors
05/21/2004WO2004004629A3 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
05/21/2004WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists
05/21/2004CA2506773A1 Heteroaryl-pyramidine derivatives as jak inhibitors
05/21/2004CA2505334A1 Substituted benzoxazinones and uses thereof
05/21/2004CA2504344A1 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
05/21/2004CA2504131A1 Derivatives of [6,7-dihydro-5h-imidazo[1,2-alpha]imidazole-3-sulfonyl]-pyrrolidine-2-carboxylic acid amide as anti-inflammatory agents
05/21/2004CA2503720A1 Gamma-aminoamide modulators of chemokine receptor activity
05/21/2004CA2503713A1 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
05/20/2004US20040097739 Ppar delta activators
05/20/2004US20040097734 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses
05/20/2004US20040097732 Peptide deformylase inhibitors
05/20/2004US20040097729 Substituted pyridine herbicides
05/20/2004US20040097728 Method for producing anellated tetrahydro-{1h}-triazoles
05/20/2004US20040097594 Sulfonamide inhibitors of aspartyl protease
05/20/2004US20040097590 Diabetes mellitus; such as 2-methyl-3-(4-(2-(5-methyl-2-thiophen-2-yl-oxazol-4-yl)-ethoxy)-phenyl)-2 -phenoxypropionic acid
05/20/2004US20040097574 For therapy of inflammatory, allergic, or proliferative processes
05/20/2004US20040097571 Imidazole compounds and their use as adenosine deaminase inhibitors
05/20/2004US20040097570 Novel benzimidazole derivatives and pharmaceutical compositions comprising these compounds
05/20/2004US20040097565 For therapy of pain associated with chronic inflammation or headache associated with hypertension
05/20/2004US20040097564 Method and compounds for treating glaucoma VI
05/20/2004US20040097552 Cyanothiophene derivatives, compositions containing such compounds and methods of use
05/20/2004US20040097547 For therapy of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer
05/20/2004US20040097546 For therapy of obesity, diabetes, sexual dysfunction, including erectile dysfunction and female sexual dysfunction
05/20/2004US20040097545 Quinolinone derivatives
05/20/2004US20040097531 For therapy of inflammatory disease, autoimmune disease, destructive bone disorder, proliferative disorder, infectious disease, neurodegenerative disease, allergy, reperfusion/ischemia in stroke, heart attack, hypoxia
05/20/2004US20040097513 Novel non-imidazole compounds
05/20/2004US20040097508 Novel heterocyclically substituted amides, their preparation and use
05/20/2004US20040097504 Compositions useful as inhibitors of jak and other protein kinases